We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 24 for:    Recruiting, Not yet recruiting, Available Studies | "Hydrocephalus"

Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02651337
Recruitment Status : Recruiting
First Posted : January 11, 2016
Last Update Posted : July 11, 2017
Sponsor:
Information provided by (Responsible Party):

December 21, 2015
January 11, 2016
July 11, 2017
March 2016
December 31, 2017   (Final data collection date for primary outcome measure)
Characterization of safe shunt catheter "flushing" using a quantitative assessment of saline injection volume (mls) required to flush the CSF shunt using the Alivio in-line Flusher. [ Time Frame: Intra-procedural ]
Quantitative assessment of saline injection volume (mls) required to flush the CSF shunt using the Alivio in-line Flusher
Same as current
Complete list of historical versions of study NCT02651337 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
The objective of this pilot study is to perform a set of pressure and flow rate measurements in order to quantitatively characterize safe irrigation or "flushing" of a ventricular shunt catheter, a routine maneuver performed by a neurosurgeon during a shunt revision surgery. This maneuver involves injecting saline with a syringe to clear plugged shunt catheters. Based on data obtained in Stage I of the study, a device has been fabricated which provides the same small-volume pulse of fluid used by surgeons. In Stage II of the study, pressure and flow rate measurements generated by this specialized flusher device will be collected and measured.

Primary Objective: To collect pressure and flow rate measurements during shunt revision surgeries in human patients.

Pressure recordings of the injected fluid will be obtained using disposable off-the-shelf sterile pressure transducers (which are typically used for intracranial and arterial pressures monitoring) readily available in the operating room. First, the surgeon will attempt to flush the catheter using the Alcyone in-line Flusher device. If this fails, the surgeon may elect to attempt to flush using a standard syringe attached to the catheter. The flow rates will be measured by video, recording the syringe during the flushing maneuver, and then extracting plunger motion information by applying image processing on the acquired videos. In the event the recording equipment is not available (in that these operations are usually unscheduled and sometimes urgent), the same irrigation techniques may be used without the pressure recordings.

Secondary Objective: To analyze the collected data and establish maximal allowable injection pressure and flow rate. The collected data segments for each patient will be analyzed and maximal values for pressure and the saline injection rate will be recorded in a spreadsheet. Inter-patient variation in the results, presumably due to different degrees of occlusion, will be statistically evaluated. We will also determine if any of the catheters which appear occluded in the operating room resume flow with the flushing maneuvers.

Interventional
Phase 3
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Hydrocephaly
Device: Cerebrospinal Fluid (CSF) Drainage
Placement of Alivio in line flusher during CSF drainage
Other Name: Alivio in line flusher
Experimental: Drainage with Alivio in-line Flusher
Volume of saline needed to drain CSF using the Alivio in-line Flusher historically compared with volume of saline needed to drain CSF using a standard syringe
Intervention: Device: Cerebrospinal Fluid (CSF) Drainage

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
February 28, 2018
December 31, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Subjects must be 30 days to 35 years of age, of any race or gender.
  2. Subjects must be scheduled to undergo a neurosurgical procedure potentially requiring a revision of neurosurgical catheters.
  3. Subjects aged >18 years of age must be willing and able to provide written informed consent. Parental consent will be required for minors.

Exclusion Criteria:

  1. Inability or unwillingness of subject or parent/guardian to give informed consent/assent.
  2. Judgment of the investigator, surgeon, or any member of the care team (including anesthesiology or operating room nursing staff) that participation in the study will interfere with, or be detrimental to, administration of optimal healthcare of the subject.
  3. Inability or unwillingness of subject to endure the test or any other condition that would preclude or bias the results of the study according to the judgment of the investigator.
Sexes Eligible for Study: All
up to 35 Years   (Child, Adult)
No
Contact: Tomer Anor, PhD 617-355-0151 Tomer.Anor@childrens.harvard.edu
Contact: Benjamin Warf, MD 617-355-4932 Benjamin.Ward@childrens.harvard.edu
United States
 
 
NCT02651337
P000009795
Yes
Not Provided
Plan to Share IPD: No
Alcyone Lifesciences, Inc.
Alcyone Lifesciences, Inc.
Not Provided
Principal Investigator: Benjamin Warf, MD Warf, MD Boston Children’s Hospital
Alcyone Lifesciences, Inc.
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP